119 related articles for article (PubMed ID: 2951159)
1. Paradoxical platelet behaviour in diabetic ketoacidosis.
Campbell RR; Foster KJ; Stirling C; Mundy D; Reckless JP
Diabet Med; 1986 Mar; 3(2):161-4. PubMed ID: 2951159
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
3. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
[TBL] [Abstract][Full Text] [Related]
4. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
Gisinger C; Schernthaner G
Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
Ferri GM; Afeltra A; Caccavo D; Amoroso A
Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
[No Abstract] [Full Text] [Related]
6. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
7. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
Gerö G; Rákóczi I; Tihanyi K; Oláh J; Demeter J; Gáti I
Haemostasis; 1985; 15(6):377-83. PubMed ID: 3908235
[TBL] [Abstract][Full Text] [Related]
8. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
9. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
10. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
Buttrick PM; Forscher CA; Sussman II; Mueller HS
Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
[TBL] [Abstract][Full Text] [Related]
11. Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
Pengo V; Boschello M; Prandoni P; Schivazappa L; Girolami A
Thromb Res; 1985 Sep; 39(5):645-50. PubMed ID: 2417360
[No Abstract] [Full Text] [Related]
12. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
13. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
14. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
[No Abstract] [Full Text] [Related]
15. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
16. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
Yamada K; Mori K; Goto Y
Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
19. Platelets and diabetic vascular disease.
Paton RC; Passa P
Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
[TBL] [Abstract][Full Text] [Related]
20. Influence of metabolic control on platelet functions in diabetic mellitus.
Janka HU; Demmel P
Horm Metab Res Suppl; 1981; 11():29-33. PubMed ID: 6274778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]